These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15149625)

  • 1. Outsourcing lead optimisation--the quiet revolution.
    Clark DE; Newton CG
    Drug Discov Today; 2004 Jun; 9(11):492-500. PubMed ID: 15149625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quiet revolution: outsourcing in pharma.
    Crossley R
    Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
    [No Abstract]   [Full Text] [Related]  

  • 3. Outsourcing lead optimization: the eye of the storm.
    Clark DE
    Drug Discov Today; 2011 Feb; 16(3-4):147-57. PubMed ID: 21145413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quiet revolution in lead optimisation services?
    Cavalla D
    Drug Discov Today; 2004 Aug; 9(15):635-6. PubMed ID: 15279844
    [No Abstract]   [Full Text] [Related]  

  • 5. Outsourcing lead optimization: constant change is here to stay.
    Clark DE
    Drug Discov Today; 2007 Jan; 12(1-2):62-70. PubMed ID: 17198974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outsourcing to exploit a key asset.
    Meerpoel L; Schroven M; Goris K; Demoen K; Marsden S
    Drug Discov Today; 2006 Jun; 11(11-12):556-60. PubMed ID: 16713908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outsourcing chemical synthesis in the drug discovery process.
    Festel G
    Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese manufacturers vie for piece of outsourcing pie.
    Jia H
    Nat Biotechnol; 2007 Dec; 25(12):1337-8. PubMed ID: 18066012
    [No Abstract]   [Full Text] [Related]  

  • 10. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outsourcing drug discovery to India and China: from surviving to thriving.
    Subramaniam S; Dugar S
    Drug Discov Today; 2012 Oct; 17(19-20):1055-8. PubMed ID: 22542471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of globalization of drug manufacturing, production, and sourcing and challenges for American drug safety.
    Woo J; Wolfgang S; Batista H
    Clin Pharmacol Ther; 2008 Mar; 83(3):494-7. PubMed ID: 18253142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical futures: made in China?
    Cyranoski D
    Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioanalytical outsourcing strategy in China.
    Dong K; Tang D
    Bioanalysis; 2017 Aug; 9(15):1157-1159. PubMed ID: 28763245
    [No Abstract]   [Full Text] [Related]  

  • 15. Schrödinger's pipeline and the outsourcing of pharmaceutical innovation.
    McMeekin P; Lendrem DW; Lendrem BC; Pratt AG; Peck R; Isaacs JD; Jones D
    Drug Discov Today; 2020 Mar; 25(3):480-484. PubMed ID: 31835019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in India.
    Maiti R; M R
    Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound scale-up at the discovery-development interface.
    Nikitenko AA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomanufacturing, from bust to boom...to bubble?
    Thiel KA
    Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
    [No Abstract]   [Full Text] [Related]  

  • 19. No immediate pain relief for the pharmaceutical industry.
    Ahlborn H; Henderson S; Davies N
    Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry.
    Dierks RML; Bruyère O; Reginster JY
    Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):147-160. PubMed ID: 29243501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.